© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Science News

Antibodies attacking COVID-19
Monoclonal Antibody Combo Authorized for COVID-19 PrEP
Pfizer Paxlovid COVID-19
FDA Authorizes First Antiviral Pill for COVID-19
Rhesus macaque
Intranasal COVID-19 Vaccine Effective in Animal Studies

COVID-19 at Any Time During Pregnancy Boosts Mother’s Risk of Death

COVID is associated with serious illness in mothers and newborns. Findings reinforce need for targeted interventions, including vaccination.

What Older Americans Need to Know About Taking Paxlovid

Before they get COVID, people over 65 should have a plan for accessing antiviral treatment.

Studies Identify Universal Predictors of Antibody Response to Vaccination

NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.

More Evidence COVID Vaccines Work Well for People With HIV

People with suppressed HIV respond well to mRNA vaccines, but individuals with a low CD4 count may not be adequately protected.

FDA Warns Evusheld May Not Protect Against Certain COVID-19 Variants

The monoclonal antibody combo is used as pre-exposure prophylaxis for immunocompromised people who may not respond to COVID-19 vaccines.

COVID-19 Vaccine for Children after MIS-C Appears Safe

NIH-supported study finds no serious complications following rare immune condition.

Moderna mRNA Vaccine Helps Prevent Cancer Recurrence

A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.
Novel coronavirus SARS-CoV-2

Two NIAID Studies Highlight COVID-19 Nasal Vaccine Potential

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

Using mRNA Technology for a Universal Flu Vaccine

A vaccine using mRNA technology induced an immune response in mice and ferrets against 20 different types of influenza.

New COVID-19 Boosters Target Current Coronavirus Variants

Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.

COVID-19 Disrupts the Gut Microbiome

COVID can also affect the gut lining, which may allow pathogenic bacteria to enter the bloodstream and cause secondary infections.

Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus

EBV is associated with certain cancers, including Hodgkin lymphoma, and autoimmune diseases, such as multiple sclerosis.

Assessing How SARS-CoV-2 Mutations Might Affect Rapid Tests

Researchers found that today’s COVID rapid antigen tests can identify all current variants of concern and interest.

Are People Living With HIV More Prone to Long COVID?

Study finds that HIV-positive people are four times more likely to experience long-term COVID symptoms.
Colorized scanning electron micrograph of a cell infected with the Omicron strain of SARS-CoV-2 virus particles (purple), isolated from a patient sample

Study Suggests COVID-19 Rebound Is Not Caused by Impaired Immune Response

The small study found no evidence of delayed development of antibodies in participants who experienced rebound after taking Paxlovid.

Study Confirms Link Between COVID-19 Vaccination and Menstrual Cycle Length

COVID-19 vaccination was associated with a temporary average increase in menstrual cycle length of less than one day.
Advertisement
Features
Newsfeed

Hot topics

face masks
Face Masks
a US dollar symbol in a life preserver
Health Equity

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.